It's 9-7 For Withdrawal Of Makena, Roche-Spark Deal Delayed Again, MRK On Watch

Today's Daily Dose brings you news about the FDA panel recommendation related to Makena; Merck's Q3 financial results; and extension of the tender offer for shares of Spark Therapeutics, to name a few.

from RTT - Biotech https://ift.tt/36fRRih
via IFTTT